Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
- PMID: 16003003
Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
Comment on
-
The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients.J Invasive Cardiol. 2005 Jun;17(6):296-9. J Invasive Cardiol. 2005. PMID: 16003002 Clinical Trial.
Similar articles
-
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?J Am Coll Cardiol. 2009 May 5;53(18):1674-6. doi: 10.1016/j.jacc.2009.02.009. J Am Coll Cardiol. 2009. PMID: 19406343 No abstract available.
-
The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients.J Invasive Cardiol. 2005 Jun;17(6):296-9. J Invasive Cardiol. 2005. PMID: 16003002 Clinical Trial.
-
[Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].Vojnosanit Pregl. 2001 Jan-Feb;58(1):65-72. Vojnosanit Pregl. 2001. PMID: 11419288 Review. Serbian. No abstract available.
-
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.Circ Cardiovasc Interv. 2009 Jun;2(3):230-6. doi: 10.1161/CIRCINTERVENTIONS.108.847996. Epub 2009 Apr 21. Circ Cardiovasc Interv. 2009. PMID: 20031720
-
Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.Z Kardiol. 2003 Mar;92(3):213-8. doi: 10.1007/s00392-003-0895-6. Z Kardiol. 2003. PMID: 12658467 Review.
Cited by
-
Comparative Proteome Analysis of Epicardial and Subcutaneous Adipose Tissues from Patients with or without Coronary Artery Disease.Int J Endocrinol. 2019 Aug 25;2019:6976712. doi: 10.1155/2019/6976712. eCollection 2019. Int J Endocrinol. 2019. PMID: 31534454 Free PMC article.
-
Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease.Sci Rep. 2021 Mar 23;11(1):6711. doi: 10.1038/s41598-021-86207-0. Sci Rep. 2021. PMID: 33758323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical